Corporate Tech Investors

Amylin Pharmaceuticals

Amylin Pharmaceuticals is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. It sells BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with Type II diabetes.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/2/2009

Transaction History

Our records indicate that Amylin Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Pascal Soriot

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Amylin Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Amunix | Analog Devices

Share this article

About Our Database of Corporate Tech Investors

The strategic investor data above is provided by VentureDeal.com, a leading supplier of corporate VC funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary